||Recombinant human ZNF395 (513 aa) fused with T7 Tag at N-terminal was expressed in E. coli.
||0.2 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, Sucrose and DTT.
||MASMTGGQQMGRGEFASVLSRRLGKRSLLGARVLGPSASEGPSAAPPSEPLLEGAAPQPFTTSDDTPCQEQPKEV LKAPSTSGLQQVAFQPGQKVYVWYGGQECTGLVEQHSWMEGQVTVWLLEQKLQVCCRVEEVWLAELQGPCPQAPP LEPGAQALAYRPVSRNIDVPKRKSDAVEMDEMMAAMVLTSLSCSPVVQSPPGTEANFSASRAACDPWKESGDISD SGSSTTSGHWSGSSGVSTPSPPHPQASPKYLGDAFGSPQTDHGFETDPDPFLLDEPAPRKRKNSVKVMYKCLWPN CGKVLRSIVGIKRHVKALHLGDTVDSDQFKREEDFYYTEVQLKEESAAAAAAAAAGTPVPGTPTSEPAPTPSMTG LPLSALPPPLHKAQSSGPEHPGPESSLPSGALSKSAPGSFWHIQADHAYQALPSFQIPVSPHIYTSVSWAAAPSA ACSLSPVRSRSLSFSEPQQPAPAMKSHLIVTSPPRAQSGARKARGEAKKCRKVYGIEHRDQWCTACRWKKACQRF LD
||>90% by SDS-PAGE
||1. May be used for in vitro mSIN3A-HDAC1 complex regulations study using recombinant ZNF395 protein intracellular delivery method.2. May be used as enzymatic substrate protein for Kinase and ubiquitin assay.3. May be used for mapping ZNF395 protein binding partner in protein–protein interaction assay in B cells.4. May be used as antigen for specific antibody development.
||Keep at -80 centigrade for long term storage. Product is stable at 4 centigrade for at least 7 days.